Evidence map›Paper›PMID 37167464›Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2023

Integrated vector management program in the framework of the COVID-19 pandemic in Medellin, Colombia

Raúl A Rojo-Ospina, Marcela Quimbayo-Forero, Arley Calle-Tobón, Sindy C Bedoya-Patiño, Maribel Gómez, Astrid Ramírez, Johnny Sánchez, Juan F Silva-Alzate, Carlos J Montes-Zuluaga, Jorge M Cadavid and 1 more

Abstract readEnglish Abstract
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Effect of Socioeconomic Strata and Land Cover on Dengue Hotspots in Medellin, Colombia.The American journal of tropical medicine and hygiene · 2025
    Article
  3. Article
  4. Therapeutic advances in infectious disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Raúl A Rojo-OspinaPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia. raul.rojo5@yahoo.es.
Marcela Quimbayo-ForeroPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia; Grupo Entomología Médica, Universidad de Antioquia, Medellín, Colombia. biomedica@ins.gov.co.
Arley Calle-TobónPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia; Grupo Entomología Médica, Universidad de Antioquia, Medellín, Colombia. biomedica@ins.gov.co.
Sindy C Bedoya-PatiñoPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia.Programa de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia. biomedica@ins.gov.co.
Maribel GómezPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia. biomedica@ins.gov.co.
Astrid RamírezPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia. biomedica@ins.gov.co.
Johnny SánchezPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia. biomedica@ins.gov.co.
Juan F Silva-AlzatePrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia. biomedica@ins.gov.co.
Carlos J Montes-ZuluagaPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia. biomedica@ins.gov.co.
Jorge M CadavidPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia; Grupo Entomología Médica, Universidad de Antioquia, Medellín, Colombia. biomedica@ins.gov.co.
Enrique A Henao-CorreaPrograma de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia.Programa de Control de Vectores, Secretaría de Salud, Alcaldía de Medellín, Medellín, Colombia. biomedica@ins.gov.co.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The COVID-19 pandemic pressured health care systems to remain alert and active in their vector-borne disease control and prevention programs, leading to changes in vector control strategies in urban areas affected by dengue, Zika and chikungunya. Objective: To describe the adaptations made to the vector control and surveillance program in Medellín during the COVID-19 health emergency. Materials and methods: Once the health emergency started, biosecurity protocols were developed. Entomological surveillance was strengthened from the institutional environment instead of homes. Data was collected in Medellín from 2018 to 2021 during the vector control and surveillance program activities, which included epidemiological and entomovirological surveillance, entomological index survey, ovitrap monitoring, community mobilization, search and elimination of mosquito breading sites, and chemical control. These actions were adapted and/or increased to promote self-care among communities in total and partial confinement, and to develop prevention and control measures. Results: Mosquito monitoring was increased by 40% using ovitraps, entomological virological surveillance showed an increase in 2020 of 34,4% compared to 2019 and virtual media was used to keep and improve contact with the community. Conclusion: The COVID-19 pandemic had a significant impact on arbovirus prevention and control programs. The city of Medellín quickly adapted its entomo-virological surveillance activities, control measures, and the contact with the community during the pandemic, which allow the Integrated Vector Management program to remain active in the city.

Indexed as

COVID-19Zika VirusZika Virus InfectionAnimalsColombiaHumansRetrospective StudiesAedesarbovirusCOVID-19denguevector borne diseases

Identifiers

PMID37167464
PMCPMC10495193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.